{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:57:14Z","timestamp":1791644234375,"version":"4.3.4"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2025\/01266-1"],"award-info":[{"award-number":["2025\/01266-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["314811\/2021-4"],"award-info":[{"award-number":["314811\/2021-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["2502\/24"],"award-info":[{"award-number":["2502\/24"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["2915\/24"],"award-info":[{"award-number":["2915\/24"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.actatropica.2026.108105","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:25:28Z","timestamp":1776813928000},"page":"108105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Trypanosoma cruzi DTU diversity, benznidazole response, and clinical manifestations of Chagas disease: a seventeen-year systematic review and meta-analysis"],"prefix":"10.1016","volume":"278","author":[{"given":"Ellen Vieira","family":"de Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Klipel da Silva","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielton dos Passos","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo Ciccone","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eros Ant\u00f4nio","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1075-8830","authenticated-orcid":false,"given":"Fernanda Ramos","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2026.108105_bib0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.actatropica.2011.08.001","article-title":"Trypanosoma cruzi I\u2013III in southern Brazil causing individual and mixed infections in humans, sylvatic reservoirs and triatomines","volume":"120","author":"Abolis","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2026.108105_bib0002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.parint.2016.12.003","article-title":"Identification of Trypanosoma cruzi discrete typing units (DTUs) in Latin-American migrants in Barcelona (Spain)","volume":"66","author":"Abras","year":"2017","journal-title":"Parasitol. Int."},{"issue":"2","key":"10.1016\/j.actatropica.2026.108105_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00152-21","article-title":"Worldwide control and management of Chagas disease in a new era of globalization: a close look at congenital Trypanosoma cruzi infection","volume":"35","author":"Abras","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2026.108105_bib0004","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7705\/biomedica.5187","article-title":"In vitro susceptibility to benznidazole, nifurtimox and posaconazole of Trypanosoma cruzi isolates from Paraguay","volume":"40","author":"Acosta","year":"2020","journal-title":"Biomedica"},{"key":"10.1016\/j.actatropica.2026.108105_bib0005","article-title":"Prevalence of Chagas disease among Latin American immigrants in non-endemic countries: an updated systematic review and meta-analysis","volume":"46","author":"Andrade","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.actatropica.2026.108105_bib0006","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1007\/s00436-015-4503-2","article-title":"Trypanosoma cruzi burden, genotypes, and clinical evaluation of Chilean patients with chronic Chagas cardiopathy","volume":"114","author":"Apt","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2026.108105_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040901","article-title":"Differential trypanocidal activity of novel macrolide antibiotics: correlation to genetic lineage","volume":"7","author":"Aquilino","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2026.108105_bib0008","doi-asserted-by":"crossref","first-page":"e00979","DOI":"10.1128\/AAC.00979-18","article-title":"Repurposing Strategy of Atorvastatin against Trypanosoma cruzi: In vitro monotherapy and combined therapy with benznidazole exhibit synergistic trypanocidal activity","volume":"62","author":"Araujo-Lima","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.actatropica.2026.108105_bib0009","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijantimicag.2010.07.003","article-title":"High antitrypanosomal activity of plant-derived sulphur-containing amides","volume":"36","author":"Astelbauer","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.actatropica.2026.108105_bib0010","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1089\/vbz.2010.0205","article-title":"Enzyme-linked immunosorbent assay and polymerase chain reaction performance using Mexican and Guatemalan discrete typing unit I strains of Trypanosoma cruzi","volume":"11","author":"Ballinas-Verdugo","year":"2011","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.actatropica.2026.108105_bib0011","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1017\/S0031182017001846","article-title":"Antichagasic effect of crotalicidin, a cathelicidin-like vipericidin, found in Crotalus durissus terrificus rattlesnake\u2019s venom gland","volume":"145","author":"Bandeira","year":"2018","journal-title":"Parasitology"},{"issue":"41","key":"10.1016\/j.actatropica.2026.108105_bib0012","first-page":"4714","article-title":"A practical green synthesis and biological evaluation of benzimidazoles against two neglected tropical diseases: Chagas and leishmaniasis","volume":"24","author":"Bandyopadhyay","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0013","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/AAC.01617-09","article-title":"Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment","volume":"54","author":"Batista","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2026.108105_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2024.108787","article-title":"Activity of pyridyl-pyrazolone derivatives against Trypanosoma cruzi","volume":"262","author":"Batista","year":"2024","journal-title":"Exp. Parasitol."},{"issue":"9","key":"10.1016\/j.actatropica.2026.108105_bib0015","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3201\/eid3109.241700","article-title":"Chagas Disease, an Endemic Disease in the United States","volume":"31","author":"Beatty","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.actatropica.2026.108105_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2024.100531","article-title":"Acrylonitrile derivatives: In vitro activity and mechanism of cell death induction against Trypanosoma cruzi and Leishmania amazonensis","volume":"24","author":"Bethencourt-Estrella","year":"2024","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.actatropica.2026.108105_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2019.104128","article-title":"Geographic distribution of Trypanosoma cruzi genotypes detected in chronic infected people from Argentina. Association with climatic variables and clinical manifestations of Chagas disease","volume":"78","author":"Bizai","year":"2020","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.actatropica.2026.108105_bib0018","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.trstmh.2011.07.003","article-title":"Urbanization of congenital transmission of Trypanosoma cruzi: prospective polymerase chain reaction study in pregnancy","volume":"105","author":"Bisio","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.actatropica.2026.108105_bib0019","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.meegid.2014.10.004","article-title":"First report of a family outbreak of Chagas disease in French Guiana and posttreatment follow-up","volume":"28","author":"Blanchet","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0020","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1016\/j.ejmech.2009.06.014","article-title":"Second generation of 2H-benzimidazole 1,3-dioxide derivatives as anti-trypanosomatid agents: synthesis, biological evaluation, and mode of action studies","volume":"44","author":"Boiani","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0021","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-pathol-020117-043711","article-title":"Pathology and pathogenesis of Chagas heart disease","volume":"14","author":"Bonney","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0022","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpddr.2016.12.004","article-title":"In vitro drug susceptibility of two strains of the wildlife trypanosome Trypanosoma copemani: A comparison with Trypanosoma cruzi","volume":"7","author":"Botero","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.actatropica.2026.108105_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111676","article-title":"Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics","volume":"183","author":"Borsari","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114876","article-title":"From rational design to serendipity: Discovery of novel thiosemicarbazones as potent trypanocidal compounds","volume":"244","author":"Braga","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004792","article-title":"Over six thousand Trypanosoma cruzi strains classified into discrete typing units (DTUs): attempt at an inventory","volume":"10","author":"Breni\u00e8re","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0026","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1286-4579(03)00050-9","article-title":"Trypanosoma cruzi clonal diversity and the epidemiology of Chagas disease","volume":"5","author":"Buscaglia","year":"2003","journal-title":"Microbes Infect"},{"key":"10.1016\/j.actatropica.2026.108105_bib0027","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejmech.2014.08.026","article-title":"Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis","volume":"85","author":"Caballero","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32877-2","article-title":"Genomic assemblies of newly sequenced Trypanosoma cruzi strains reveal new genomic expansion and greater complexity","volume":"8","author":"Callejas-Hern\u00e1ndez","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2026.108105_bib0029","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12879-020-4851-0","article-title":"Fatal acute Chagas disease by Trypanosoma cruzi DTU TcI, Ecuador","volume":"20","author":"Calvopina","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/microorganisms10020287","article-title":"Genetic diversity of Trypanosoma cruzi in Panama inferred by multi-locus sequence typing of mitochondrial genes","volume":"10","author":"Calzada","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.actatropica.2026.108105_bib0031","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/jam.14391","article-title":"Antichagasic effect of violacein from Chromobacterium violaceum","volume":"127","author":"Canuto","year":"2019","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0032","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2174\/1573406416666200121105215","article-title":"Synthesis, antitrypanosomal and antimycobacterial activities of coumarin N-acylhydrazonic derivatives","volume":"17","author":"Capelini","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0033","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","article-title":"Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de uma nova entidade morbida do homem","volume":"1","author":"Chagas","year":"1909","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0034","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1590\/S0074-02761922000200004","article-title":"Descoberta do Tripanozoma cruzi e verifica\u00e7\u00e3o da tripanozomiase americana: retrospecto hist\u00f3rico","volume":"15","author":"Chagas","year":"1922","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0035","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.3390\/molecules26123510","article-title":"Intrinsic and chemotherapeutic stressors modulate ABCC-like transport in Trypanosoma cruzi","volume":"26","author":"Costa","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.actatropica.2026.108105_bib0036","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13071-015-1039-3","article-title":"Chagas disease reactivation in a heart transplant patient infected by domestic Trypanosoma cruzi discrete typing unit I (TcIDOM)","volume":"8","author":"Costales","year":"2015","journal-title":"Parasites & Vectors"},{"issue":"Suppl. 1","key":"10.1016\/j.actatropica.2026.108105_bib0037","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1590\/S0074-02762009000900006","article-title":"Epidemiology, control and surveillance of Chagas disease-100 years after its discovery","volume":"104","author":"Coura","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0038","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cytogfr.2021.10.001","article-title":"Chagas disease: Immunology of the disease at a glance","volume":"62","author":"Cristov\u00e3o-Silva","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.actatropica.2026.108105_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010386","article-title":"Use of benznidazole to treat chronic Chagas disease: an updated systematic review with a meta-analysis","volume":"16","author":"Crespillo-And\u00fajar","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0040","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1017\/S0031182011002186","article-title":"Trypanosoma cruzi discrete typing units in Chagas disease patients from endemic and non-endemic regions of Argentina","volume":"139","author":"Cura","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2026.108105_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003765","article-title":"Multiplex Real-Time PCR assay using TaqMan probes for the identification of Trypanosoma cruzi DTUs in biological and clinical samples","volume":"9","author":"Cura","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0042","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jac\/dkr140","article-title":"In vitro trypanocidal activity of DB745B and other novel arylimidamides against Trypanosoma cruzi","volume":"66","author":"Da Silva","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2026.108105_bib0043","article-title":"In vitro and in vivo investigation of the efficacy of arylimidamide DB1831 and its mesylated salt form - DB1965 - against Trypanosoma cruzi infection","volume":"7","author":"Da Silva","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2026.108105_bib0044","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2017.02.026","article-title":"Design and synthesis of potent anti-Trypanosoma cruzi agents: new thiazole derivatives which induce apoptotic parasite death","volume":"130","author":"Da Silva","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.exppara.2015.05.012","article-title":"In vivo and in vitro auranofin activity against Trypanosoma cruzi: possible new uses for an old drug","volume":"166","author":"Da Silva","year":"2016","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.actatropica.2026.108105_bib0046","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s13071-016-1754-4","article-title":"Ecological scenario and Trypanosoma cruzi DTU characterization of a fatal acute Chagas disease case transmitted orally (Esp\u00edrito Santo state, Brazil)","volume":"9","author":"Dario","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.actatropica.2026.108105_bib0047","article-title":"Synthesis and in vitro antiprotozoal evaluation of novel Knoevenagel hydroxychloroquine derivatives","volume":"6","author":"Dario","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0048","first-page":"431","article-title":"In vitro and in silico analysis of imatinib analogues as anti-Trypanosoma cruzi drug candidates","volume":"150","author":"De Freitas","year":"2023","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2026.108105_bib0049","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946202163048","article-title":"Suspected vertical transmission of Chagas disease caused by DTU TcIV in an infection probably transmitted orally, during an outbreak in the Brazilian Amazon","volume":"63","author":"De Freitas","year":"2021","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.actatropica.2026.108105_bib0050","article-title":"Detection of Trypanosoma cruzi DTUs TcI and TcIV in two outbreaks of orally-transmitted Chagas disease in the Northern region of Brazil","volume":"65","author":"De Freitas","year":"2023","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"10.1016\/j.actatropica.2026.108105_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107993","article-title":"Discovery of a new eugenol-benznidazole hybrid active against different evolutive stages of Trypanosoma cruzi","volume":"154","author":"De Melo","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0052","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejmech.2017.09.047","article-title":"Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi","volume":"141","author":"De Oliveira Filho","year":"2017","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.actatropica.2026.108105_bib0053","article-title":"Quantification of parasite burden of Trypanosoma cruzi and identification of Discrete Typing Units (DTUs) in blood samples of Latin American immigrants residing in Barcelona, Spain","volume":"14","author":"De Oliveira","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.665624","article-title":"Intra-Discrete Typing Unit TcV genetic variability of Trypanosoma cruzi in chronic Chagas\u2019 disease Bolivian immigrant patients in Barcelona, Spain","volume":"8","author":"De Oliveira","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.actatropica.2026.108105_bib0055","article-title":"Correlation of TcII discrete typing units with severe chronic Chagas cardiomyopathy in patients from various Brazilian geographic regions","volume":"16","author":"De Oliveira","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"10422","key":"10.1016\/j.actatropica.2026.108105_bib0056","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01787-7","article-title":"Chagas disease","volume":"403","author":"De Sousa","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2026.108105_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000687","article-title":"Lineage analysis of circulating Trypanosoma cruzi parasites and their association with clinical forms of Chagas disease in Bolivia","volume":"4","author":"Del Puerto","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0058","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1590\/S0074-02762002000500002","article-title":"The impact of Chagas disease control in Latin America","volume":"97","author":"Dias","year":"2002","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0059","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1186\/s13071-015-1218-2","article-title":"Acute Chagas outbreaks: molecular and biological features of Trypanosoma cruzi isolates, and clinical aspects of acute cases in Santander, Colombia","volume":"8","author":"D\u00edaz","year":"2015","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.actatropica.2026.108105_bib0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1017\/S0950268813000757","article-title":"Trypanosoma cruzi genotyping supports a common source of infection in a school-related oral outbreak of acute Chagas disease in Venezuela","volume":"142","author":"D\u00edaz-Bello","year":"2014","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.actatropica.2026.108105_bib0062","article-title":"Clarifying the misuse of EC50, IC50, and LC50 in cytotoxicity study of water disinfection byproducts: A critical analysis and perspective","volume":"15","author":"Du","year":"2025","journal-title":"Hyg. Environ. Heal. Adv."},{"key":"10.1016\/j.actatropica.2026.108105_bib0063","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1590\/0074-02760140208","article-title":"The TcI and TcII Trypanosoma cruzi experimental infections induce distinct immune responses and cardiac fibrosis in dogs","volume":"109","author":"Duz","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0064","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946201961027","article-title":"Fatal evolution of acute Chagas disease in a child from Northern Brazil: factors that determine poor prognosis","volume":"61","author":"Esper","year":"2019","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.actatropica.2026.108105_bib0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.actatropica.2014.08.006","article-title":"The innate immune response status correlates with a divergent clinical course in congenital Chagas disease of twins born in a non-endemic country","volume":"140","author":"Fern\u00e1ndez-Villegas","year":"2014","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2026.108105_bib0066","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12101217","article-title":"Trypanosoma cruzi STIB980: A TcI strain for drug discovery and reverse genetics","volume":"12","author":"Fesser","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.actatropica.2026.108105_bib0067","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.medcli.2016.10.038","article-title":"Orally-transmitted Chagas disease","volume":"148","author":"Filigheddu","year":"2017","journal-title":"Med. Clin."},{"key":"10.1016\/j.actatropica.2026.108105_bib0068","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejmech.2016.03.036","article-title":"Antichagasic and trichomonacidal activity of 1-substituted 2-benzyl-5-nitroindazolin-3-ones and 3-alkoxy-2-benzyl-5-nitro-2H-indazoles","volume":"115","author":"Fonseca-Berzal","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0069","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1017\/S0031182016001098","article-title":"Biological approaches to characterize the mode of action of two 5-nitroindazolinone prototypes on Trypanosoma cruzi bloodstream trypomastigotes","volume":"143","author":"Fonseca-Berzal","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2026.108105_bib0070","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/cmdc.201800084","article-title":"Antichagasic, leishmanicidal, and trichomonacidal activity of 2-benzyl-5-nitroindazole-derived amines","volume":"13","author":"Fonseca-Berzal","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.actatropica.2026.108105_bib0071","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1017\/S0031182020000955","article-title":"Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant Trypanosoma cruzi Y strain (DTU TcII): in vitro and in vivo studies","volume":"147","author":"Fonseca-Berzal","year":"2020","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2026.108105_bib0072","first-page":"82","article-title":"Drug Discovery for Chagas Disease: impact of different host cell lines on assay performance and hit compound selection","volume":"4","author":"Franco","year":"2019","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0073","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0014-4894(03)00119-X","article-title":"Trypanosoma cruzi: mixture of two populations can modify virulence and tissue tropism in rat","volume":"104","author":"Franco","year":"2003","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0074","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.meegid.2015.01.030","article-title":"ABCG-like transporter of Trypanosoma cruzi involved in benznidazole resistance: gene polymorphisms disclose inter-strain intragenic recombination in hybrid isolates","volume":"31","author":"Franco","year":"2015","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.toxicon.2020.04.099","article-title":"Wasp venom peptide as a new antichagasic agent","volume":"181","author":"Freire","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.actatropica.2026.108105_bib0076","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.meegid.2017.01.016","article-title":"Molecular identification and genotyping of Trypanosoma cruzi DNA in autochthonous Chagas disease patients from Texas, USA","volume":"49","author":"Garcia","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0077","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.170773","article-title":"Prostaglandin F2\u03b1 synthase in Trypanosoma cruzi plays critical roles in oxidative stress and susceptibility to benznidazole","volume":"4","author":"Garc\u00eda-Huertas","year":"2017","journal-title":"R Soc Open Sci"},{"key":"10.1016\/j.actatropica.2026.108105_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112020","article-title":"Advances in the treatment of Chagas disease: Promising new drugs, plants and targets","volume":"142","author":"Garc\u00eda-Huertas","year":"2021","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.actatropica.2026.108105_bib0079","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/cmdc.202000331","article-title":"Dual parasiticidal activities of phthalimides: Synthesis and biological profile against Trypanosoma cruzi and Plasmodium falciparum","volume":"15","author":"Gomes","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.actatropica.2026.108105_bib0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.htct.2018.12.001","article-title":"Chagas disease and transfusion medicine: a perspective from non-endemic countries","volume":"41","author":"G\u00f3mez","year":"2019","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"10.1016\/j.actatropica.2026.108105_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110416","article-title":"Pharmacological potential of new metronidazole\/eugenol\/dihydroeugenol hybrids against Trypanosoma cruzi in vitro and in vivo","volume":"121","author":"Gon\u00e7alves-Santos","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0082","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/ph19010030","article-title":"Inhibitory activity of LDT10 and LDT119, new saturated cardanols, against Trypanosoma cruzi","volume":"19","author":"Granado","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.actatropica.2026.108105_bib0083","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.exppara.2010.05.010","article-title":"Trypanosoma cruzi: biological characterization of an isolate from an endemic area and its susceptibility to conventional drugs","volume":"126","author":"Grosso","year":"2010","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0084","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.exppara.2018.02.002","article-title":"Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection","volume":"186","author":"Gulin","year":"2018","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0085","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.855119","article-title":"Miltefosine and benznidazole combination improve anti-Trypanosoma cruzi in vitro and in vivo efficacy","volume":"12","author":"Gulin","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0086","article-title":"Molecular diagnosis of Trypanosoma cruzi infection in Colombia: parasitic loads and discrete typing units in patients from acute and chronic phases","volume":"10","author":"Hern\u00e1ndez","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.actatropica.2026.108105_bib0087","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/pharmaceutics13050705","article-title":"Tambjamines and Prodiginines: Biocidal Activity against Trypanosoma cruzi","volume":"13","author":"Herr\u00e1ez","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actatropica.2026.108105_bib0088","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0512-2018","article-title":"Reactivation of Chagas disease in a heart transplant patient infected by sylvatic Trypanosoma cruzi discrete typing unit I","volume":"52","author":"Inga","year":"2019","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"7","key":"10.1016\/j.actatropica.2026.108105_bib0089","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005058","article-title":"Utilizing chemical genomics to identify cytochrome b as a novel drug target for Chagas disease","volume":"11","author":"Khare","year":"2015","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.actatropica.2026.108105_bib0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bjid.2016.10.010","article-title":"Differential expression on mitochondrial tryparedoxin peroxidase (mTcTXNPx) in Trypanosoma cruzi after ferrocenyl diamine hydrochlorides treatments","volume":"21","author":"Kohatsu","year":"2017","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0091","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ejmech.2017.12.052","article-title":"Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: identification of a promising hit compound","volume":"144","author":"Lara","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0092","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/bcp.14700","article-title":"Review of pharmacological options for the treatment of Chagas disease","volume":"88","author":"Lascano","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0093","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241921","article-title":"Mixed infections by different Trypanosoma cruzi discrete typing units among Chagas disease patients in an endemic community in Panama","volume":"15","author":"Ledezma","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2026.108105_bib0094","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/cbdd.13333","article-title":"New 1,2,3-triazole-based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations","volume":"92","author":"Leite","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"issue":"10","key":"10.1016\/j.actatropica.2026.108105_bib0095","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1021\/acsinfecdis.8b00284","article-title":"Organometallic Gold(III) Complex [Au(Hdamp)(L14)]+ (L1 = SNS-Donating Thiosemicarbazone) as a Candidate to New Formulations against Chagas Disease","volume":"5","author":"Lopes","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0096","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/pathogens8040172","article-title":"Withanolides from Withania aristata as antikinetoplastid agents through induction of programmed cell death","volume":"8","author":"L\u00f3pez-Arencibia","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.actatropica.2026.108105_bib0097","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11686-025-01125-9","article-title":"Analysis of the behavior of Trypanosoma cruzi in culture against different dosage forms of benznidazole: experimental insights","volume":"70","author":"L\u00f3pez-Dom\u00ednguez","year":"2025","journal-title":"Acta Parasit"},{"key":"10.1016\/j.actatropica.2026.108105_bib0098","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7705\/biomedica.v29i3.15","article-title":". In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole","volume":"29","author":"Luna","year":"2009","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.actatropica.2026.108105_bib0099","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2020.105361","article-title":"Contemporary autochthonous human Chagas disease in the USA","volume":"205","author":"Lynn","year":"2020","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2026.108105_bib0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.fitote.2016.04.005","article-title":"Bioactivity-guided isolation of laevicarpin, an antitrypanosomal and anticryptococcal lactam from Piper laevicarpu (Piperaceae)","volume":"111","author":"Maciel","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1016\/j.actatropica.2026.108105_bib0101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006612","article-title":"Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery","volume":"12","author":"MacLean","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0102","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1016\/S2666-5247(21)00265-2","article-title":"Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human\u2013host interactions","volume":"3","author":"Magalh\u00e3es","year":"2022","journal-title":"Lancet Microbe"},{"issue":"4","key":"10.1016\/j.actatropica.2026.108105_bib0103","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.humpath.2009.11.005","article-title":"Mixed infection of Trypanosoma cruzi I and II in a Colombian cardiomyopathic patient","volume":"41","author":"Mantilla","year":"2010","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0104","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.actatropica.2018.05.004","article-title":"Discrete typing units of Trypanosoma cruzi detected by real-time PCR in Chilean patients with chronic Chagas cardiomyopathy","volume":"185","author":"Mart\u00edn","year":"2018","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2026.108105_bib0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejmech.2018.12.034","article-title":"New polyamine drugs as more effective antichagas agents than benznidazole in both the acute and chronic phases","volume":"164","author":"Mart\u00edn-Escolano","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpddr.2019.03.003","article-title":"Insights into Chagas treatment based on the potential of bacteriocin AS-48","volume":"10","author":"Mart\u00edn-Escolano","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.actatropica.2026.108105_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106679","article-title":"Biological characteristics of the Trypanosoma cruzi Arequipa strain make it a good model for Chagas disease drug discovery","volume":"236","author":"Mart\u00edn-Escolano","year":"2022","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2026.108105_bib0108","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/vbz.2012.1072","article-title":"Microsatellite and mini-exon analysis of Mexican human DTU I Trypanosoma cruzi strains and their susceptibility to nifurtimox and benznidazole","volume":"13","author":"Mart\u00ednez","year":"2013","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.actatropica.2026.108105_bib0109","article-title":"Biological features of TcM: A new Trypanosoma cruzi isolate from Argentina classified into TcV lineage","volume":"3","author":"Martinez","year":"2022","journal-title":"Curr. Res. Microb. Sci."},{"key":"10.1016\/j.actatropica.2026.108105_bib0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1590\/S0074-02762001000100006","article-title":"Biological characterization of Trypanosoma cruzi strains","volume":"96","author":"Mart\u00ednez-D\u00edaz","year":"2001","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0111","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.actatropica.2016.01.032","article-title":"Prevalence of Trypanosoma cruzi\u2019s discrete typing units in a cohort of Latin American migrants in Spain","volume":"157","author":"Martinez-Perez","year":"2016","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2026.108105_bib0112","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.actatropica.2013.10.002","article-title":"Prevalence of Chagas disease in Brazil: a systematic review and meta-analysis","volume":"130","author":"Martins-Melo","year":"2014","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2026.108105_bib0113","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2147\/JEP.S267378","article-title":"Review on experimental treatment strategies against Trypanosoma cruzi","volume":"13","author":"Mazzeti","year":"2021","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0114","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7705\/biomedica.v32i2.458","article-title":"Sensibilidad al benzonidazol de cepas de Trypanosoma cruzi sugiere la circulaci\u00f3n de cepas naturalmente resistentes en Colombia","volume":"32","author":"Mej\u00eda-Jaramillo","year":"2012","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.actatropica.2026.108105_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117782","article-title":"Cationic and anionic PLGA-cholesterol hybrid nanoparticles as promising platforms to enhance the trypanocidal efficacy of benznidazole and drug delivery in Trypanosoma cruzi-infected cells","volume":"183","author":"Medeiros","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.actatropica.2026.108105_bib0116","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejmech.2015.04.028","article-title":"Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents","volume":"96","author":"Mendoza-Mart\u00ednez","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0117","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1586\/14787210.2015.1056158","article-title":"Between a bug and a hard place: Trypanosoma cruzi genetic diversity and clinical outcomes","volume":"13","author":"Messenger","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.actatropica.2026.108105_bib0118","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exppara.2014.08.014","article-title":"Comparative pathogenicity in Swiss mice of Trypanosoma cruzi IV from northern Brazil and Trypanosoma cruzi II from southern Brazil","volume":"146","author":"Meza","year":"2014","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.actatropica.2026.108105_bib0119","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.actatropica.2006.12.001","article-title":"Trypanosoma cruzi strains, Tulahuen 2 and Y, besides the difference in resistance to oxidative stress, display differential glucose-6-phosphate and 6-phosphogluconate dehydrogenases activities","volume":"101","author":"Mielniczki-Pereira","year":"2007","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2026.108105_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104329","article-title":"Potential association of Trypanosoma cruzi DTUs TcV and TcVI with the digestive form of Chagas disease","volume":"84","author":"Monje-Rumi","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0121","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2020.107930","article-title":"Antichagasic effect of hemocyanin derived from antimicrobial peptides of Penaeus monodon shrimp","volume":"215","author":"Monteiro","year":"2020","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114624","article-title":"Rational design of a trypanocidal peptide derived from Dinoponera quadriceps venom","volume":"241","author":"Monteiro","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041284","article-title":"Trypanosoma cruzi IV causing outbreaks of acute Chagas disease and infections by different haplotypes in the western Brazilian Amazonia","volume":"7","author":"Monteiro","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2026.108105_bib0124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002069","article-title":"Trypanosoma cruzi I and IV stocks from Brazilian Amazon are divergent in terms of biological and medical properties in mice","volume":"7","author":"Monteiro","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.actatropica.2026.108105_bib0125","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1590\/S0074-02762010000700014","article-title":"Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease","volume":"105","author":"Moreno","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0126","article-title":"Mitochondrial Sirtuin TcSir2rp3 affects TcSODA activity and oxidative stress response in Trypanosoma cruzi","volume":"11","author":"Moura","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0127","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.665063","article-title":"Characterization and follow-up of Trypanosoma cruzi natural populations refractory to etiological chemotherapy in oral Chagas Disease patients","volume":"11","author":"Mu\u00f1oz-Calder\u00f3n","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0128","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1021\/acsinfecdis.2c00569","article-title":"Genetic characterization of Trypanosoma cruzi I populations from an oral Chagas disease outbreak in Venezuela: natural resistance to nitroheterocyclic drugs","volume":"9","author":"Mu\u00f1oz-Calder\u00f3n","year":"2023","journal-title":"ACS Infect. Dis."},{"issue":"17","key":"10.1016\/j.actatropica.2026.108105_bib0129","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.3390\/molecules24173168","article-title":"Hybrids of Cinchona Alkaloids and Bile Acids as Antiparasitic Agents Against Trypanosoma cruzi","volume":"24","author":"Musikant","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.actatropica.2026.108105_bib0130","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1021\/acsmedchemlett.0c00106","article-title":"Development of selective steroid inhibitors for the glucose-6-phosphate dehydrogenase from Trypanosoma cruzi","volume":"11","author":"Naciuk","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.actatropica.2026.108105_bib0131","article-title":"Biological characterization of Trypanosoma cruzi epimastigotes derived from trypomastigotes isolated from Brazilian chagasic patients","volume":"3","author":"Nakamura","year":"2022","journal-title":"Curr. Res. Microb. Sci."},{"issue":"4","key":"10.1016\/j.actatropica.2026.108105_bib0132","doi-asserted-by":"crossref","first-page":"609","DOI":"10.26538\/tjnpr\/v5i4.2","article-title":"Evaluation of in vitro antiprotozoal and cytotoxic activities of selected medicinal plants used in Nigerian folk medicine","volume":"5","author":"Nnadi","year":"2021","journal-title":"Trop. J. Nat. Prod. Res."},{"key":"10.1016\/j.actatropica.2026.108105_bib0133","article-title":"Prevalence of clinical forms of Chagas disease: a systematic review and meta-analysis \u2013 data from the RAISE study","volume":"30","author":"Nascimento","year":"2024","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.actatropica.2026.108105_bib0134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243008","article-title":"Association between Trypanosoma cruzi DTU TcII and chronic Chagas disease clinical presentation and outcome in an urban cohort in Brazil","volume":"15","author":"Nielebock","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2026.108105_bib0135","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2013.05.046","article-title":"Chagas disease: an overview of clinical and epidemiological aspects","volume":"62","author":"Nunes","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0136","doi-asserted-by":"crossref","first-page":"e002236","DOI":"10.1128\/AAC.02236-20","article-title":"In vitro susceptibility of Kinetoplastids to celastroloids from Maytenus chiapensis","volume":"65","author":"N\u00fa\u00f1ez","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.actatropica.2026.108105_bib0137","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/zph.13038","article-title":"Identification of a triatomine infected with Trypanosoma cruzi in an urban area of the state of Veracruz, Mexico: A comprehensive study","volume":"70","author":"Ochoa-Mart\u00ednez","year":"2023","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.actatropica.2026.108105_bib0138","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11686-024-00986-w","article-title":"Expression analysis of thirteen genes in response to nifurtimox and benznidazole in Mexican isolates of Trypanosoma cruzi by digital PCR","volume":"70","author":"Ochoa-Mart\u00ednez","year":"2025","journal-title":"Acta Parasitol"},{"key":"10.1016\/j.actatropica.2026.108105_bib0139","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.exppara.2015.05.014","article-title":"Effects of artesunate against Trypanosoma cruzi","volume":"156","author":"Olivera","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2025.100623","article-title":"Comparative transcriptomics of naturally susceptible and resistant Trypanosoma cruzi strains in response to benznidazole","volume":"29","author":"Ospina","year":"2025","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.actatropica.2026.108105_bib0141","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.actatropica.2026.108105_bib0142","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejmech.2017.12.011","article-title":"Investigating the structure\u2013activity relationships of N\u2019-[(5-nitrofuran-2-yl)methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds","volume":"144","author":"Palace-Berl","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0143","article-title":"Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates","volume":"13","author":"Palacio","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2026.108105_bib0144","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00284-22","article-title":"Drug repurposing in Chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi in vitro and in vivo","volume":"66","author":"Pandey","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2026.108105_bib0145","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4269\/ajtmh.17-0417","article-title":"Trypanosoma cruzi detection in Colombian patients with a diagnosis of esophageal achalasia","volume":"98","author":"Panesso-G\u00f3mez","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2026.108105_bib0146","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.abb.2012.02.020","article-title":"Tryparedoxin peroxidases and superoxide dismutases expression as well as ROS release are related to Trypanosoma cruzi epimastigotes growth phases","volume":"520","author":"Peloso","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.actatropica.2026.108105_bib0147","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.actatropica.2017.11.002","article-title":"The effect of reinfection and mixed Trypanosoma cruzi infections on disease progression in mice","volume":"178","author":"Perez","year":"2018","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2026.108105_bib0148","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2026.108105_bib0149","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2019.105161","article-title":"Mapping benznidazole resistance in trypanosomatids and exploring evolutionary histories of nitroreductases and ABCG transporter protein sequences","volume":"200","author":"Petravicius","year":"2019","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2026.108105_bib0150","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400059","article-title":"New 2-nitroimidazole-N-acylhydrazones, analogs of benznidazole, as anti-Trypanosoma cruzi agents","volume":"357","author":"Pitombeira","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.actatropica.2026.108105_bib0151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091154","article-title":"Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study)","volume":"9","author":"Poveda","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2026.108105_bib0152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000899","article-title":"Chagas cardiomyopathy manifestations and Trypanosoma cruzi genotypes circulating in chronic chagasic patients","volume":"4","author":"Ram\u00edrez","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0153","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/pathogens14010072","article-title":"Molecular Markers for the Phylogenetic Reconstruction of Trypanosoma cruzi: A Quantitative Review","volume":"14","author":"Ram\u00edrez-Delgado","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.actatropica.2026.108105_bib0154","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s13071-019-3766-3","article-title":"Trypanosoma cruzi infection associated with atypical clinical manifestation during the acute phase of the Chagas disease","volume":"12","author":"Rangel-Gamboa","year":"2019","journal-title":"Parasites & Vectors"},{"key":"10.1016\/j.actatropica.2026.108105_bib0155","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1186\/s12864-018-5198-4","article-title":"Whole genome sequencing of Trypanosoma cruzi field isolates reveals extensive genomic variability and complex aneuploidy patterns within TcII DTU","volume":"19","author":"Reis-Cunha","year":"2018","journal-title":"BMC Genomics"},{"key":"10.1016\/j.actatropica.2026.108105_bib0156","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115622","article-title":"Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi","volume":"258","author":"Reis","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2026.108105_bib0157","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/pathogens8040197","article-title":"In vitro benznidazole and nifurtimox susceptibility profile of Trypanosoma cruzi strains belonging to discrete typing units TcI, TcII, and TcV","volume":"8","author":"Revollo","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.actatropica.2026.108105_bib0158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000846","article-title":"Coinfection with different Trypanosoma cruzi strains interferes with the host immune response to infection","volume":"4","author":"Rodrigues","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006939","article-title":"Exploring the parasite load and molecular diversity of Trypanosoma cruzi in patients with chronic Chagas disease from different regions of Brazil","volume":"12","author":"Rodrigues-Dos-Santos","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0160","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3390\/pharmaceutics17101271","article-title":"Design, synthesis, in vitro and in silico biological evaluation of new pyridine-2,5-dicarboxylates esters bearing natural source fragments as anti-trypanosomatid agents","volume":"17","author":"S\u00e1nchez-Palestino","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actatropica.2026.108105_bib0161","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/1756-3305-7-267","article-title":"Trypanosoma cruzi strain TcI is associated with chronic Chagas disease in the Brazilian Amazon","volume":"7","author":"Santana","year":"2014","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.actatropica.2026.108105_bib0162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010845","article-title":"Disruption of multiple copies of the Prostaglandin F2alpha synthase gene affects oxidative stress response and infectivity in Trypanosoma cruzi","author":"Santi","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0163","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760240279","article-title":"Chagas disease in Brazil: new challenges and perspectives for old problems","volume":"120","author":"Santos","year":"2025","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0164","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1590\/S0074-02761997000600018","article-title":"The Trypanosoma cruzi genome project: nuclear karyotype and gene mapping of clone CL Brener","volume":"92","author":"Santos","year":"1997","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0165","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/iai.59.2.645-654.1991","article-title":"Attachment of Trypanosoma cruzi to mammalian cells requires parasite energy, and invasion can be independent of the target cell cytoskeleton","volume":"59","author":"Schenkman","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2026.108105_bib0166","first-page":"288","article-title":"In vitro effects of aminopyridyl ligands complexed to copper(II) on the physiology and interaction process of Trypanosoma cruzi","volume":"8","author":"Silva-Oliveira","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0167","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1342431","article-title":"New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes","volume":"15","author":"Silvestrini","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0168","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1128\/AAC.01788-15","article-title":"Phenotypic screening in vitro of novel aromatic amidines against Trypanosoma cruzi","volume":"60","author":"Sim\u00f5es-Silva","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2026.108105_bib0169","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1128\/AAC.00070-13","article-title":"In vitro and in vivo studies of the antiparasitic activity of sterol 14\u03b1-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi","volume":"57","author":"Soeiro","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2026.108105_bib0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jep.2017.08.042","article-title":"Trypanocidal activity of polysaccharide extract from Genipa americana leaves","volume":"210","author":"Souza","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.actatropica.2026.108105_bib0171","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.diagmicrobio.2007.07.016","article-title":"Characterization of Trypanosoma cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil","volume":"60","author":"Steindel","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.actatropica.2026.108105_bib0172","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exppara.2018.04.016","article-title":"In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: a multivariate approach","volume":"189","author":"Strauss","year":"2018","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003707","article-title":"The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence","volume":"9","author":"Taylor","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2026.108105_bib0174","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/antibiotics10010024","article-title":"Aniba rosaeodora (Var. amazonica Ducke) essential oil: chemical composition, antibacterial, antioxidant and antitrypanosomal activity","volume":"10","author":"Teles","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.actatropica.2026.108105_bib0175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13071-019-3485-9","article-title":"Drug transporter and oxidative stress gene expression in human macrophages infected with benznidazole-sensitive and naturally benznidazole-resistant Trypanosoma cruzi parasites treated with benznidazole","volume":"12","author":"T\u00e9llez","year":"2019","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.actatropica.2026.108105_bib0176","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.exppara.2016.03.013","article-title":"Differential parasitological, molecular, and serological detection of Trypanosoma cruzi I, II, and IV in blood of experimentally infected mice","volume":"166","author":"Teston","year":"2016","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.actatropica.2026.108105_bib0177","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2021.108136","article-title":"Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon","volume":"228","author":"Teston","year":"2021","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0178","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1017\/S0031182014000407","article-title":"In vitro investigation of the efficacy of novel diamidines against Trypanosoma cruzi","volume":"141","author":"Timm","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2026.108105_bib0179","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116307","article-title":"Microencapsulation of Theobroma cacao L polyphenols: a high-value approach with in vitro anti-Trypanosoma cruzi, immunomodulatory and antioxidant activities","volume":"173","author":"Vargas-Mun\u00e9var","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.actatropica.2026.108105_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009269","article-title":"In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: a systematic review and meta-analysis","volume":"15","author":"Vela","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"8","key":"10.1016\/j.actatropica.2026.108105_bib0181","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00688-17","article-title":"Efficacy of a binuclear cyclopalladated compound therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis and its inhibitory effect on topoisomerase 1B","volume":"61","author":"Vel\u00e1squez","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2026.108105_bib0182","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41597-022-01452-w","article-title":"Discrete typing units of Trypanosoma cruzi: geographical and biological distribution in the Americas","volume":"9","author":"Vel\u00e1squez-Ortiz","year":"2022","journal-title":"Sci. Data"},{"key":"10.1016\/j.actatropica.2026.108105_bib0183","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.parint.2012.04.007","article-title":"Chronic Chagas disease with cardiodigestive involvement and the TcVI infective form of Trypanosoma cruzi: a case report","volume":"61","author":"Vicco","year":"2012","journal-title":"Parasitology International"},{"key":"10.1016\/j.actatropica.2026.108105_bib0184","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exppara.2004.07.001","article-title":"Lack of correlation between in vitro susceptibility to benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease","volume":"108","author":"Villarreal","year":"2004","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2026.108105_bib0185","series-title":"Chagas disease (American trypanosomiasis)","year":"2026"},{"key":"10.1016\/j.actatropica.2026.108105_bib0186","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013627","article-title":"Genetic diversity of Trypanosoma cruzi in individuals with chronic Chagas disease in the Northern Minas Gerais and Vale do Jequitinhonha regions, Minas Gerais, Brazil","volume":"19","author":"Xavier","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.actatropica.2026.108105_bib0187","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1590\/S0074-02762009000700021","article-title":"A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI","volume":"104","author":"Zingales","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0188","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1590\/0074-0276140156","article-title":"Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity","volume":"109","author":"Zingales","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0189","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/0074-02760140407","article-title":"A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole","volume":"110","author":"Zingales","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2026.108105_bib0190","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3390\/life13122339","article-title":"Fifteen years after defining T. cruzi DTUs: what have we learned?","volume":"13","author":"Zingales","year":"2023","journal-title":"Life"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X26001397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X26001397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:19:14Z","timestamp":1784812754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X26001397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":189,"alternative-id":["S0001706X26001397"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2026.108105","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trypanosoma cruzi DTU diversity, benznidazole response, and clinical manifestations of Chagas disease: a seventeen-year systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2026.108105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108105"}}